生殖系PTEN基因型依赖的表型差异在前脑类器官早期神经发育中的表现
该研究利用基因编辑等基因人诱导多能干细胞(hiPSC)构建前脑类器官,模拟PTENG132D(孤独症谱系障碍相关)与PTENM134R(癌症相关)突变对神经发育的影响。结果显示PTENG132D在类器官生成最初几天即破坏早期神经外胚层形成并导致电生理缺陷,而PTENM134R在此阶段形态与野生型相似;两种突变在发育72天以上均出现神经元分化、放射状胶质细胞定位和皮质分层异常。AKT抑制剂哌立福辛可减少过度激活的AKT并部分纠正PTENG132D类器官的细胞组织异常。
要点
- PTENG132D突变在类器官早期即破坏神经外胚层形成并导致电生理缺陷。
- 两种PTEN突变在发育72天以上均出现神经元分化与皮质分层异常。
- AKT抑制剂哌立福辛可部分纠正PTENG132D类器官的细胞组织异常。
核心结论
- 不同PTEN错义突变可在不同阶段对神经发育产生深远影响,进而可能使PHTS个体易患ASD。
研究设计与样本
- 研究从携带PTENG132D(ASD)或PTENM134R(癌症)突变等位基因的基因编辑等基因hiPSC生成前脑类器官培养物。
主要发现
- PTENG132D等位基因在类器官生成最初几天破坏早期神经外胚层形成并导致电生理缺陷。
- PTENM134R hiPSC来源的类器官在早期阶段形态与野生型相似。
- 两种PTEN突变类器官在发育72天以上均出现神经元分化、放射状胶质细胞定位和皮质分层异常。
- 哌立福辛(AKT抑制剂)减少过度激活的AKT并部分纠正PTENG132D类器官的细胞组织异常。
- 早期类器官单细胞RNA测序显示PTENG132D突变类器官中神经细胞命运相关基因减少,AKT抑制可上调神经元细胞命运和CNS成熟通路相关基因特征。
临床怎么用
- 提示PHTS患者需关注ASD相关神经发育监测,尤其携带PTENG132D突变者。
- AKT信号通路可能是PTEN突变相关神经发育异常的潜在干预靶点,但尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PTEN germline mutations account for ~0.2-1% of all autism spectrum disorder (ASD) cases, as well as ~17% of ASD patients with macrocephaly, making it one of the top ASD-associated risk genes. Individuals with germline PTEN mutations receive the molecular diagnosis of PTEN Hamartoma Tumor Syndrome (PHTS), an inherited cancer predisposition syndrome, about 20-23% of whom are diagnosed with ASD. We generated forebrain organoid cultures from gene-edited isogenic human induced pluripotent stem cells (hiPSCs) harboring a PTENG132D (ASD) or PTENM134R (cancer) mutant allele to model how these mutations interrupt neurodevelopmental processes. Here, we show that the PTENG132D allele disrupts early neuroectoderm formation during the first several days of organoid generation, and results in deficient electrophysiology. While organoids generated from PTENM134R hiPSCs remained morphologically similar to wild-type organoids during this early stage in development, we observed disrupted neuronal differentiation, radial glia positioning, and cortical layering in both PTEN-mutant organoids at the later stage of 72+ days of development. Perifosine, an AKT inhibitor, reduced over-activated AKT and partially corrected the abnormalities in cellular organization observed in PTENG132D organoids. Single cell RNAseq analyses on early-stage organoids revealed that genes related to neural cell fate were decreased in PTENG132D mutant organoids, and AKT inhibition was capable of upregulating gene signatures related to neuronal cell fate and CNS maturation pathways. These findings demonstrate that different PTEN missense mutations can have a profound impact on neurodevelopment at diverse stages which in turn may predispose PHTS individuals to ASD. Further study will shed light on ways to mitigate pathological impact of PTEN mutants on neurodevelopment by stage-specific manipulation of downstream PTEN signaling components.
引用
- Kang SC, Sarn NB, Venegas J, et al. Germline PTEN genotype-dependent phenotypic divergence during the early neural developmental process of forebrain organoids. Mol Psychiatry. 2023. PMID: 38030818. doi:10.1038/s41380-023-02325-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。